1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Aesthetic Injectables Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Aesthetic Injectables Market Revenue and Volume, by Product
8.1.1 Hyaluronic Acid (HA)
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Botulinum Toxin (Botox)
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Aquatic Light Injections
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Volume Forecast
9.1. Aesthetic Injectables Market Revenue and Volume, by End-use
9.1.1. Medical Spas
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Dermatology Clinics
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Hospitals
9.1.3.1. Market Revenue and Volume Forecast
10.1. Aesthetic Injectables Market Revenue and Volume, by Application
10.1.1. Facial Line Correction
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Lip Augmentation
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Face Lift
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Acne Scar Treatment
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Lipoatrophy Treatment
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product
11.1.2. Market Revenue and Volume Forecast, by End-use
11.1.3. Market Revenue and Volume Forecast, by Application
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product
11.1.4.2. Market Revenue and Volume Forecast, by End-use
11.1.4.3. Market Revenue and Volume Forecast, by Application
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product
11.1.5.2. Market Revenue and Volume Forecast, by End-use
11.1.5.3. Market Revenue and Volume Forecast, by Application
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product
11.2.2. Market Revenue and Volume Forecast, by End-use
11.2.3. Market Revenue and Volume Forecast, by Application
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product
11.2.4.2. Market Revenue and Volume Forecast, by End-use
11.2.4.3. Market Revenue and Volume Forecast, by Application
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product
11.2.5.2. Market Revenue and Volume Forecast, by End-use
11.2.5.3. Market Revenue and Volume Forecast, by Application
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product
11.2.6.2. Market Revenue and Volume Forecast, by End-use
11.2.6.3. Market Revenue and Volume Forecast, by Application
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product
11.2.7.2. Market Revenue and Volume Forecast, by End-use
11.2.7.3. Market Revenue and Volume Forecast, by Application
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product
11.3.2. Market Revenue and Volume Forecast, by End-use
11.3.3. Market Revenue and Volume Forecast, by Application
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product
11.3.4.2. Market Revenue and Volume Forecast, by End-use
11.3.4.3. Market Revenue and Volume Forecast, by Application
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product
11.3.5.2. Market Revenue and Volume Forecast, by End-use
11.3.5.3. Market Revenue and Volume Forecast, by Application
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product
11.3.6.2. Market Revenue and Volume Forecast, by End-use
11.3.6.3. Market Revenue and Volume Forecast, by Application
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product
11.3.7.2. Market Revenue and Volume Forecast, by End-use
11.3.7.3. Market Revenue and Volume Forecast, by Application
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product
11.4.2. Market Revenue and Volume Forecast, by End-use
11.4.3. Market Revenue and Volume Forecast, by Application
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product
11.4.4.2. Market Revenue and Volume Forecast, by End-use
11.4.4.3. Market Revenue and Volume Forecast, by Application
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product
11.4.5.2. Market Revenue and Volume Forecast, by End-use
11.4.5.3. Market Revenue and Volume Forecast, by Application
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product
11.4.6.2. Market Revenue and Volume Forecast, by End-use
11.4.6.3. Market Revenue and Volume Forecast, by Application
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product
11.4.7.2. Market Revenue and Volume Forecast, by End-use
11.4.7.3. Market Revenue and Volume Forecast, by Application
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product
11.5.2. Market Revenue and Volume Forecast, by End-use
11.5.3. Market Revenue and Volume Forecast, by Application
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product
11.5.4.2. Market Revenue and Volume Forecast, by End-use
11.5.4.3. Market Revenue and Volume Forecast, by Application
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product
11.5.5.2. Market Revenue and Volume Forecast, by End-use
11.5.5.3. Market Revenue and Volume Forecast, by Application
12.1. Allergan Aesthetics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Galderma
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merz Aesthetics
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Revance Therapeutics
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Ipsen Aesthetic
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Evolus
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Sinclair Pharma
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Hugel Inc
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Medytox
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Bloomage Biotech
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
